Guangdong Transtek Medical Electronics Co., Ltd
SZSE:300562.SZ
10.84 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 884.257 | 1,065.097 | 1,821.072 | 1,336.748 | 883.668 | 775.103 | 866.59 | 770.644 | 629.006 | 455.71 | 380.848 | 323.5 | 233.076 |
| Cost of Revenue
| 610.688 | 812.716 | 1,483.369 | 1,002.41 | 669.164 | 574.239 | 632.078 | 515.97 | 459.029 | 328.797 | 283.792 | 247.454 | 180.997 |
| Gross Profit
| 273.569 | 252.38 | 337.703 | 334.338 | 214.505 | 200.864 | 234.512 | 254.674 | 169.976 | 126.913 | 97.056 | 76.046 | 52.079 |
| Gross Profit Ratio
| 0.309 | 0.237 | 0.185 | 0.25 | 0.243 | 0.259 | 0.271 | 0.33 | 0.27 | 0.278 | 0.255 | 0.235 | 0.223 |
| Reseach & Development Expenses
| 108.323 | 136.932 | 149.153 | 96.519 | 68.673 | 56.404 | 66.117 | 59.346 | 37.54 | 23.385 | 13.517 | 0 | 0 |
| General & Administrative Expenses
| 25.087 | 18.784 | 24.412 | 11.974 | 9.931 | 10.396 | 10.999 | 10.554 | 9.006 | 8.183 | 4.71 | 30.4 | 22.732 |
| Selling & Marketing Expenses
| 71.681 | 67.072 | 97.751 | 92.544 | 69.079 | 75.034 | 103.057 | 76.382 | 53.018 | 24.668 | 24.75 | 12.038 | 6.183 |
| SG&A
| 96.768 | 85.856 | 122.164 | 104.517 | 79.009 | 85.43 | 114.057 | 86.935 | 62.024 | 32.852 | 29.46 | 42.438 | 28.915 |
| Other Expenses
| 33.951 | -3.451 | -3.295 | -0.765 | -0.794 | -0.981 | 13.446 | 10.902 | 12.037 | 3.611 | 4.232 | 1.13 | 0.346 |
| Operating Expenses
| 239.043 | 268.58 | 321.153 | 236.982 | 181.135 | 172.631 | 219.958 | 179.091 | 125.358 | 78.452 | 60.505 | 44.133 | 30.249 |
| Operating Income
| 34.526 | -41.115 | 0.085 | 72.169 | 37.643 | 26.507 | 12.277 | 83.322 | 46.927 | 49.331 | 37.446 | 33.213 | 26.525 |
| Operating Income Ratio
| 0.039 | -0.039 | 0 | 0.054 | 0.043 | 0.034 | 0.014 | 0.108 | 0.075 | 0.108 | 0.098 | 0.103 | 0.114 |
| Total Other Income Expenses Net
| -1.415 | -3.451 | -3.295 | -0.242 | -0.794 | 1.989 | 13.446 | 9.469 | 11.854 | 3.481 | 4.221 | 1.122 | 0.346 |
| Income Before Tax
| 33.111 | -44.566 | -3.209 | 71.927 | 36.849 | 28.496 | 25.723 | 93.374 | 58.781 | 52.812 | 41.667 | 34.335 | 26.871 |
| Income Before Tax Ratio
| 0.037 | -0.042 | -0.002 | 0.054 | 0.042 | 0.037 | 0.03 | 0.121 | 0.093 | 0.116 | 0.109 | 0.106 | 0.115 |
| Income Tax Expense
| 1.914 | -6.436 | -2.934 | 4.034 | 6.955 | 6.461 | 8.259 | 12.853 | 8.592 | 7.472 | 6.499 | 5.67 | 4.614 |
| Net Income
| 34.367 | -32.293 | 8.869 | 70.162 | 31.064 | 24.016 | 17.841 | 80.521 | 50.189 | 45.34 | 35.168 | 28.664 | 22.257 |
| Net Income Ratio
| 0.039 | -0.03 | 0.005 | 0.052 | 0.035 | 0.031 | 0.021 | 0.104 | 0.08 | 0.099 | 0.092 | 0.089 | 0.095 |
| EPS
| 0.16 | -0.15 | 0.041 | 0.37 | 0.16 | 0.13 | 0.09 | 0.55 | 0.36 | 0.33 | 0.26 | 0.21 | 0 |
| EPS Diluted
| 0.16 | -0.15 | 0.041 | 0.37 | 0.16 | 0.13 | 0.09 | 0.55 | 0.36 | 0.33 | 0.26 | 0.21 | 0 |
| EBITDA
| 74.374 | -5.208 | 23.552 | 90.383 | 56.638 | 51.017 | 35.636 | 82.621 | 63.613 | 56.334 | 45.231 | 34.545 | 23.415 |
| EBITDA Ratio
| 0.084 | 0.037 | 0.021 | 0.068 | 0.057 | 0.06 | 0.043 | 0.107 | 0.108 | 0.125 | 0.116 | 0.109 | 0.091 |